Dorsey Wright & Associates

Position in ROIV — Roivant Sciences Ltd.

CIK 1376772 PASADENA, CA

Position in ROIV

as of Jun 30, 2026 · filed Aug 6, 2026 Compact

Position Value

$13,860,918

-$2,126,053 QoQ

Shares Held

391,662

-32.1% QoQ

Ownership

0.054%

of shares outstanding

% of Portfolio

2.62%

of 13F equity value

Holder Rank

#94

of 494 holders

Holding Since

Dec 2025

3 quarters on record

Voting authority Sole 100% Shared 0% None 0%

Healthcare · as of Jun 30, 2026

Dorsey Wright & Associates holds $27,470,218 across 5 Biotechnology names. ROIV ranks #1 (50.5% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	ROIV	Roivant Sciences Ltd. This page	391,662	$13,860,918
2	ARWR	Arrowhead Pharmaceuticals, Inc.	97,466	$7,944,453
3	ASND	Ascendis Pharma A/S	8,427	$2,247,649
4	ABVX	Abivax S.A.	16,645	$2,218,112
5	DBVT	DBV Technologies S.A.	73,115	$1,199,086

3 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$13,860,918	391,662	-32.1%	Shares	Sole	2026-08-06
2026-03-31	$15,986,971	577,147	+53.5%	Shares	Sole	2026-05-06
2025-12-31	$8,161,500	376,106	—	Shares	Sole	2026-02-20
No filing history on record for this holder in this stock.